Operon™ Platform-Enabled for Cardiometabolic Biomarker Screening and Precision Treatment Strategies: A Type 2 Diabetes-Centered Review with Cardiovascular Extension.

Saved in:
Bibliographic Details
Title: Operon™ Platform-Enabled for Cardiometabolic Biomarker Screening and Precision Treatment Strategies: A Type 2 Diabetes-Centered Review with Cardiovascular Extension.
Authors: Jenkins, Ian1 (AUTHOR), Casazza, Krista2 (AUTHOR), Narayan, Vaishnavi1,3 (AUTHOR), Lernhardt, Waldemar1 (AUTHOR), Savich, Valentina1,2 (AUTHOR), Uffens, Jayson1,3 (AUTHOR), Gutierrez-Castrellon, Pedro3 (AUTHOR), Lakey, Jonathan R. T.1,2 (AUTHOR) jrtlakey@gmail.com
Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p3969. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first